Endeavor

FDA Approval Marks New Era for Pancreatic Cancer Treatment

First-in-class targeted therapy nearly doubles median overall survival for patients with metastatic pancreatic cancer

FDA Approves Rusfertide, Offering a New Option for Polycythemia Vera

For Danielle Sweet, the weekly injection helped end nearly four years of exhausting phlebotomy

Dolly Parton’s Death Shines Light on the Power of Clinical Trials

Her sister’s tribute revealed Dolly’s wish to help future cancer patients

Moffitt Launches Radiopharmaceutical Program at Speros

Treatment targets cancer cells more precisely using radioactive isotopes

Could Sugary Drinks Affect Stomach Cancer Risk?

People who regularly consumed sugar-sweetened beverages had a higher risk of developing stomach cancer, according to a recent study

Can AI Help Multidisciplinary Teams Make Complex Treatment Decisions?

Moffitt researchers are developing an AI tool to capture and summarize complex, fast-moving discussions about patient care

Can Augmented Reality Help People Quit Smoking and Vaping?

Moffitt researchers are bringing a proven behavioral approach out of the clinic and into the real world, using smartphones to help people manage nicotine cravings where they happen

New FDA-Approved Therapy Offers Hope for Patients With Advanced Melanoma

A first-of-its-kind oncolytic viral immunotherapy combination offers a new option for patients

Can Removing Your Fallopian Tubes Prevent Ovarian Cancer?

A national study led by Karen Lu, MD finds a two-step surgical approach may preserve quality of life for women at high genetic risk while researchers continue studying its long-term effectiveness